Patents by Inventor Subba Reddy Katamreddy

Subba Reddy Katamreddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
    Publication number: 20120077812
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Application
    Filed: November 30, 2011
    Publication date: March 29, 2012
    Inventors: JING FANG, Jun Tang, Andrew J. Carpenter, Gregory Peckham, Christopher R. Conlee, Kien S. Du, Subba Reddy Katamreddy
  • Bicyclic compounds and use as antidiabetics
    Patent number: 8101634
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: January 24, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Jing Fang, Jun Tang, Andrew J Carpenter, Gregory Peckham, Christopher R Conlee, Kien S Du, Subba Reddy Katamreddy
  • Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
    Publication number: 20100261772
    Abstract: The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
    Type: Application
    Filed: May 24, 2010
    Publication date: October 14, 2010
    Inventors: Jing Fang, Dennis Heyer, Subba Reddy Katamreddy, Kenneth William Batchelor, Richard Dana Caldwell
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Patent number: 7799828
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: September 21, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, Jr., William J. Zuercher, Subba Reddy Katamreddy
  • Cycloalkylidene compounds as selective estrogen receptor modulators
    Patent number: 7723393
    Abstract: The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: May 25, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Jing Fang, Dennis Heyer, Subba Reddy Katamreddy, Kenneth William Batchelor, Richard Dana Caldwell
  • BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
    Publication number: 20100029650
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Application
    Filed: December 5, 2007
    Publication date: February 4, 2010
    Inventors: Jing Fang, Jun Tang, Andrew J. Carpenter, Gregory Peckham, Christopher R. Conlee, Kien S. Du, Subba Reddy Katamreddy
  • Naphthalene compounds as selective estrogen receptor modulators
    Patent number: 7649093
    Abstract: The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: January 19, 2010
    Assignee: Glaxo Smith Kline LLC
    Inventors: Dennis Heyer, Jing Fang, Frank Navas, III, Subba Reddy Katamreddy, Jennifer Poole Peckham, Philip Stewart Turnbull, Aaron Bayne Miller, Adwoa Akwabi-Ameyaw
  • Cycloalkylidene Compounds As Modulators of Estrogen Receptor
    Publication number: 20090253659
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: June 8, 2009
    Publication date: October 8, 2009
    Inventors: Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, JR., William J. Zuercher, Subba Reddy Katamreddy
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Patent number: 7569601
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: August 4, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, Jr., William J. Zuercher, Subba Reddy Katamreddy
  • Cycloalkylidene compounds as modulators of estrogen receptor
    Patent number: 7560589
    Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
    Type: Grant
    Filed: July 27, 2004
    Date of Patent: July 14, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Jonathan E. Britton, Jing Fang, Dennis Heyer, Aaron Bayne Miller, Frank Navas, III, Terrence Lee Smalley, Jr., William J. Zuercher, Subba Reddy Katamreddy
  • Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators
    Publication number: 20080319078
    Abstract: Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: November 22, 2006
    Publication date: December 25, 2008
    Inventor: Subba Reddy Katamreddy
  • Triphenylethylene Compounds Useful as Selective Estrogen Modulators
    Publication number: 20080306036
    Abstract: Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: November 22, 2006
    Publication date: December 11, 2008
    Inventor: Subba Reddy Katamreddy
  • Triphenylethylene compounds as selective estrogen receptor modulators
    Patent number: 7442833
    Abstract: Compounds of formula (I): with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.
    Type: Grant
    Filed: October 4, 2004
    Date of Patent: October 28, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: John Fred Eaddy, III, Dennis Heyer, Amarjit Sab Randhawa, Vicente Samano, John Albert Ray, Subba Reddy Katamreddy, Michael Tolar Martin, Michael Scott McClure
  • Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators
    Publication number: 20080255078
    Abstract: Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: November 22, 2006
    Publication date: October 16, 2008
    Inventor: Subba Reddy Katamreddy
  • Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators
    Publication number: 20080255089
    Abstract: Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: November 22, 2006
    Publication date: October 16, 2008
    Inventor: Subba Reddy Katamreddy
  • Chemical Compounds
    Publication number: 20080234199
    Abstract: Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.
    Type: Application
    Filed: November 22, 2006
    Publication date: September 25, 2008
    Inventor: Subba Reddy Katamreddy
  • Cycloalkylidene Compounds as Selective Estrogen Receptor Modulators
    Publication number: 20080167360
    Abstract: The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
    Type: Application
    Filed: May 24, 2006
    Publication date: July 10, 2008
    Inventors: Jing Fang, Dennis Heyer, Subba Reddy Katamreddy, Kenneth William Batchelor, Richard Dana Caldwell